Medical News

RSS

Despite recession, some states boosting insurance coverage

"Despite the economic downturn that's busting state budgets from Sacramento to Tallahassee, 26 states this year made it easier for low-income children, parents or pregnant women to get health coverage, according to a report released Tuesday by the Kaiser Family Foundation," Kaiser Health News and The Miami Herald report (KHN is a program of the foundation).

9 Dec 2009

MLL team finds 454 Sequencing technology promising for leukemia genetic characterization

This week at the 51st American Society for Hematology Annual Meeting, a team of researchers from the MLL Munich Leukemia Laboratory presented results from a series of groundbreaking studies which explore alternative, high-throughput 454 Sequencing methods for distinguishing and characterizing the many forms of leukemia and myeloproliferative disorders.

9 Dec 2009

Drug makers attract scrutiny over cost and ads, but may benefit from overhaul

Drug makers came under scrutiny after the AARP published research recently showing their wholesale prices had increased by an average of 9.3 percent during the past year, offsetting the value of rebates the industry promised as part of a health care overhaul to help seniors pay for drugs.

9 Dec 2009

Study finds one third of American adults serves as a caregiver

"A new study says almost one out of three adults in the U.S. currently serves as a caregiver," NPR reports. "The time and energy they put into caregiving becomes like an unpaid job. On average, they spend about 19 hours a week providing care, doing everything from bathing and dressing an elderly parent or loved one to balancing a checkbook or doing household chores."

9 Dec 2009

Aetna understated profits, overhead, lawmakers say

Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.

9 Dec 2009

RegeneRx Biopharmaceuticals completes Phase I trial evaluating systemic administration of RGN-352

REGENERX BIOPHARMACEUTICALS, INC. announced today that it has completed and analyzed the safety data from its double-blind, placebo controlled Phase I clinical trial evaluating the systemic administration of RGN-352. The trial included testing of a single escalating intravenous dose of the drug candidate on forty healthy volunteers in Phase IA and, subsequently, over a fourteen-day treatment period on forty volunteers in Phase IB.

9 Dec 2009

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

9 Dec 2009

USPTO grants CyDex Pharmaceuticals patent for Captisol

CyDex Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company entitled “Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof.” This patent, along with other previously issued technology patents, will provide broader protection for CyDex’s Captisol® technology until 2028.

9 Dec 2009

Misuse of blood thinners in dialysis patients reported

Reuters/ABC News reports on research published in the Journal of the American Medical Association that examined the misuse of two blood thinners - Lovenox and Integrilin - in "about 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery [who] are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said Tuesday.

9 Dec 2009

Decision Resources reports increased uptake of TNF-alpha inhibitors for Crohn's disease

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that compared to last year's analysis of U.S. patient-level claims data, TNF-alpha inhibitors are being used more often to treat newly diagnosed patients suffering from Crohn's disease.

9 Dec 2009

Medicare to pay for HIV testing

Reuters: "Americans enrolled in the U.S. government-run Medicare health insurance program will now be covered for tests that screen for HIV, The Centers for Medicare and Medicaid Services (CMS), which oversees the program for the elderly and disabled, said on Tuesday.

9 Dec 2009

NPH acquires an exclusive license from UCLA for a suite of supramolecular nanoparticle technologies

NanoPacific Holdings, Inc. (NPH) announces the acquisition of an exclusive license from University of California at Los Angeles (UCLA) for a suite of supramolecular nanoparticle technologies. Under the terms of the agreement between NPH and UCLA, NPH will have an exclusive worldwide license of a system composed of a ternary mixture of modular components that self-assemble into supramolecular nanoparticles.

9 Dec 2009

NYSE Amex to delist Cortex Pharmaceuticals

Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company’s non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company’s common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.

9 Dec 2009

Watson Pharmaceuticals' RAPAFLO demonstrates safety and tolerability in BPH treatment

Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.

9 Dec 2009

Hi-Tech Pharmacal reports net sales of $40.9M for the quarter ended October 31, 2009

Hi-Tech Pharmacal Co., Inc. today reported results for the quarter ended October 31, 2009.

9 Dec 2009

Waters begins shipping its ground-breaking SYNAPT G2 Mass Spectrometer

Waters Corporation announced today that it has shipped the first units of its ground-breaking SYNAPT(TM) G2 Mass Spectrometer, first introduced at the 2009 American Society of Mass Spectrometry (ASMS) annual conference in Philadelphia in June.

9 Dec 2009

CORD:USE Cord Blood Bank awarded contract to supply blood units for the NCBI

CORD:USE Cord Blood Bank is proud to announce that the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services has awarded CORD:USE Cord Blood Bank a three-year, multi-million dollar contract to expand the supply of cord blood units for the National Cord Blood Inventory (NCBI).

9 Dec 2009

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Osteologix Inc. announced today that the company anticipates that it will be prepared to file a marketing application in 2011 in the European Union for its proprietary second-generation strontium therapy, NB S101 (strontium malonate). If successful, this will be Osteologix' first marketing approval of NB S101 for the treatment of postmenopausal osteoporosis.

9 Dec 2009

Unigene Laboratories announces reduction in workforce and operating expenses

Unigene Laboratories, Inc. has announced a restructuring plan that includes a reduction in workforce to improve operational efficiencies and to better match resources with market demand and the Company’s strategic objectives.

9 Dec 2009

PHYH spins off Phyhealth Corporation

Physicians Healthcare Management Group, Inc., today announced that it is spinning off its wholly-owned subsidiary, Phyhealth Corporation ("Phyhealth"). Phyhealth will assume substantially all the businesses, assets and liabilities of PHYH at the time of, or prior to, the spin-off.

9 Dec 2009

Medical News

Despite recession, some states boosting insurance coverage

MLL team finds 454 Sequencing technology promising for leukemia genetic characterization

Drug makers attract scrutiny over cost and ads, but may benefit from overhaul

Study finds one third of American adults serves as a caregiver

Aetna understated profits, overhead, lawmakers say

RegeneRx Biopharmaceuticals completes Phase I trial evaluating systemic administration of RGN-352

White House announces $600 million for community health centers, medical records

USPTO grants CyDex Pharmaceuticals patent for Captisol

Misuse of blood thinners in dialysis patients reported

Decision Resources reports increased uptake of TNF-alpha inhibitors for Crohn's disease

Medicare to pay for HIV testing

NPH acquires an exclusive license from UCLA for a suite of supramolecular nanoparticle technologies

NYSE Amex to delist Cortex Pharmaceuticals

Watson Pharmaceuticals' RAPAFLO demonstrates safety and tolerability in BPH treatment

Hi-Tech Pharmacal reports net sales of $40.9M for the quarter ended October 31, 2009

Waters begins shipping its ground-breaking SYNAPT G2 Mass Spectrometer

CORD:USE Cord Blood Bank awarded contract to supply blood units for the NCBI

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Unigene Laboratories announces reduction in workforce and operating expenses

PHYH spins off Phyhealth Corporation

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News